Regional brain distribution of [18F]GBR 13119, a dopamine uptake inhibitor, in CD-1 and C57BL/6 mice

Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice

Richard E. Heikkila, Arthur Hess, Roger C. Duvoisin · Science · 1984 · 1K citations

A simple quantitative bradykinesia test in MPTP-treated mice.

N Ogawa, Yuki Hirose, S Ohara et al. · PubMed · 1985 · 337 citations

Neurophysiology, Medicine, Dopamine Concentration +12

Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra

G.A. Ricaurte, Ian Irwin, L.S. Forno et al. · Brain Research · 1987 · 185 citations

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Degeneration, Substantia Nigra, Dopaminergic Neurons +10

[3H]GBR 12935 binding in vivo in mouse brain: labelling of a piperazine acceptor site

Peter H. Andersen, Jens Aas Jansen, Erik B. Nielsen · European Journal of Pharmacology · 1987 · 57 citations

Molecular Neuroscience, Medicine, Neurotransmitter +9

Biodistribution, dosimetry, metabolism and monkey PET studies of [18F]GBR 13119. Imaging the dopamine uptake system in vivo

Michael R. Kilbourn, James E. Carey, Robert A. Koeppe et al. · International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology · 1989 · 46 citations · Full text

Positron Emission Tomography, Medicine, Dopamine Uptake System +7